Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Non-Current Debt (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Non-Current Debt for 16 consecutive years, with $875000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Non-Current Debt fell 89.47% to $875000.0 in Q4 2025 year-over-year; TTM through Nov 2025 was $875000.0, a 89.47% decrease, with the full-year FY2025 number at $875000.0, down 89.47% from a year prior.
  • Non-Current Debt was $875000.0 for Q4 2025 at Cryo Cell International, down from $8.2 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $8.6 million in Q3 2022 to a low of $875000.0 in Q1 2021.
  • A 5-year average of $3.6 million and a median of $875000.0 in 2021 define the central range for Non-Current Debt.
  • Peak YoY movement for Non-Current Debt: skyrocketed 883.91% in 2022, then crashed 89.84% in 2023.
  • Cryo Cell International's Non-Current Debt stood at $875000.0 in 2021, then changed by 0.0% to $875000.0 in 2022, then changed by 0.0% to $875000.0 in 2023, then soared by 849.72% to $8.3 million in 2024, then plummeted by 89.47% to $875000.0 in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Non-Current Debt are $875000.0 (Q4 2025), $8.2 million (Q3 2025), and $875000.0 (Q2 2025).